Senores Pharmaceuticals IPO opens on December 20, 2024, and closes on December 24, 2024. This is a Book Built Issue IPO. The company aims to raise ₹582.11 crores through the IPO, comprising a fresh issue of ₹500 crores and offer for sale of 21,00,000 equity shares. The price band is ₹372 to ₹391 per share. The retail quota is 10%, QIB is 75%, and HNI is 15%. The IPO is set to list on BSE & NSE on December 30, 2024. The allotment date for the IPO is December 26, 2024. Senores Pharmaceuticals reported revenue of ₹217.34 crores in 2024, compared to ₹39.02 crores in 2023. The company incurred a loss of ₹32.71 crores in 2024, compared to a profit of ₹8.43 crores in 2023. As per the financials, the IPO investors should apply for the IPO for a long-term investment.
Senores Pharmaceuticals IPO Details
Field
Value
est listing
675 (72.63%)
gain percentage
53.45%
gmp
284
ipo size
₹ 582.11 Cr
ipo title
Senores Pharmaceuticals IPO
price
391
status
Listed
subscription
97.86x
Senores Pharmaceuticals IPO Dates
Field
Value
boa dt
26-Dec
close
24-Dec
listing
30-Dec
lot
38
open
20-Dec
Senores Pharmaceuticals IPO Financial Report
Senores Pharmaceuticals reported revenue of ₹217.34 crores in 2024, up from ₹39.02 crores in 2023. However, the company reported a loss of ₹32.71 crores in 2024, compared to a profit of ₹8.43 crores in 2023.
No Data Available
About Senores Pharmaceuticals IPO
Senores Pharmaceuticals specializes in generic medicines and has global certifications from food and drug authorities. The company focuses on innovation, production, and manufacturing, aiming to make healthcare products more affordable and accessible. Senores Pharmaceuticals also manufactures critical care injectables and active pharmaceutical ingredients (APIs). With a significant presence in the US and Canada, they also operate in 43 other countries, further broadening their reach.
Senores Pharmaceuticals IPO Registrar
Link Intime India Private Limited
Phone: +91 8108114949
Email: senorespharma.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/
Company Address
Senores Pharmaceuticals Limited
1101 to 1103, 11th Floor, South Tower, ONE 42
Opposite Jayantilal Park, Ambali Bopal Road, Ahmedabad, Gujarat, India, 380054
Phone: +91 -79-29999857
Email: cs@senorespharma.com
Website: www.senorespharma.com
Senores Pharmaceuticals IPO FAQs
What is Senores Pharmaceuticals IPO?
Senores Pharmaceuticals IPO is a mainboard IPO aiming to raise ₹582.11 crores. The issue price range is ₹372 to ₹391 per equity share, and the IPO will be listed on BSE & NSE.
When will Senores Pharmaceuticals IPO open for subscription?
The IPO will open on December 20, 2024, and close on December 24, 2024.
What is Senores Pharmaceuticals IPO Investors' Portion?
The allocation is 75% for QIB, 15% for HNI, and 10% for Retail investors.
How to apply for Senores Pharmaceuticals IPO?
You can apply for Senores Pharmaceuticals IPO via ASBA online via your bank account, UPI through stock brokers, or offline applications via brokers.
What is Senores Pharmaceuticals IPO Issue Size?
The issue size is ₹582.11 crores.
What is Senores Pharmaceuticals IPO Price Band?
The price band is ₹372 to ₹391 per share.
What is Senores Pharmaceuticals IPO Lot Size?
The minimum bid size is 38 shares, costing ₹14,858.
What is the Senores Pharmaceuticals IPO Allotment Date?
The allotment date is December 26, 2024.
What is the Senores Pharmaceuticals IPO Listing Date?
The IPO will be listed on December 30, 2024, on BSE & NSE.
About GMPSHARE
Gmpshare Pvt. Ltd.
4-158/9 5th Cross Road, Sainikpuri, Secunderabad - 500094, TS, IND
